Valuation: Mega Genomics Limited

Market Cap 1.39B 1.62B 207M 185M 172M 157M 295M 20B 297M 2.07B 809M 10.17B 776M 759M 32.7B P/E 2024
47.5x
P/E 2025 49.1x
Enterprise Value 977M 1.14B 146M 130M 121M 110M 208M 14.1B 209M 1.46B 570M 7.17B 547M 535M 23.05B EV / Sales 2024
11.5x
EV / Sales 2025 4.44x
Free-Float
42.99%
Yield 2024 *
-
Yield 2025 2.23%
1 day+0.41%
1 week+4.06%
Current month+4.06%
1 month+3.33%
3 months-2.41%
6 months-0.54%
Current year+1.39%
1 week 6.8
Extreme 6.795
7.3
1 month 6.5
Extreme 6.5
7.3
Current year 5
Extreme 5
7.53
1 year 5
Extreme 5
7.53
3 years 5
Extreme 5
12.4
5 years 5
Extreme 5
21
10 years 5
Extreme 5
21
Manager TitleAgeSince
Chief Executive Officer 46 2024-01-16
Chief Tech/Sci/R&D Officer 46 -
Chief Operating Officer 43 -
Director TitleAgeSince
Director/Board Member 46 -
Director/Board Member 45 2021-08-05
Director/Board Member 48 2021-08-05
Date Insider Type Main position Quantity % Market Cap. Importance
9/10/26 Other

Founder

-1,000,000 0.4458%
1/21/25 Other

Director

273,970 0.1181%
1/21/25 Other

Founder

800,000 0.3448%
Change 5-day change 1-year change 3-year change Capi.($)
+0.41%+4.06%+0.14%-8.75% 205M
+1.76%+2.64%+14.04%+25.82% 111B
+1.61%+2.91%+0.37%+78.98% 93.57B
-1.27%-4.29%+134.71%+808.29% 57.75B
-0.21%-2.18%-5.47%+55.95% 27.77B
+0.08%+1.25%+11.57%+54.91% 25.28B
-0.58%-2.58%+24.83%+82.72% 25.21B
-0.18%+0.71%-16.14%-2.69% 21.31B
+0.53%+1.67%+26.85%+321.39% 20.81B
-0.60%+15.93%+8.61%+81.18% 19.55B
Average +0.16%+2.41%+19.95%+149.78% 40.2B
Weighted average by Cap. +0.62%+1.79%+26.16%+174.55%

Financials

2024 2025
Net sales 164M 192M 24.49M 21.89M 20.42M 18.55M 34.93M 2.37B 35.19M 245M 95.86M 1.21B 91.95M 89.97M 3.87B 247M 289M 36.86M 32.94M 30.73M 27.91M 52.57M 3.57B 52.96M 369M 144M 1.81B 138M 135M 5.83B
Net income 45.04M 52.73M 6.72M 6M 5.6M 5.09M 9.58M 650M 9.65M 67.3M 26.29M 331M 25.22M 24.68M 1.06B 27.02M 31.63M 4.03M 3.6M 3.36M 3.05M 5.75M 390M 5.79M 40.37M 15.77M 198M 15.13M 14.8M 637M
Net Debt -459M -537M -68.42M -61.13M -57.04M -51.81M -97.57M -6.62B -98.3M -685M -268M -3.37B -257M -251M -10.82B -409M -479M -61M -54.5M -50.85M -46.19M -86.99M -5.9B -87.64M -611M -239M -3B -229M -224M -9.65B
Projected Income Statement - Annual - Mega Genomics Limited
Logo Mega Genomics Limited
Mega Genomics Ltd is an investment holding company primarily engaged in the provision of genetic testing and cancer screening services. The Company operates through Namely Consumer Genetic Testing Services segment and Cancer Screening Services segment. The Company's testing services include Brain Health Assessment Package, Alimentation Capability Assessment Package, Parkinson's Disease Risk Assessment, Full-scale Cancer Risk Assessment Package, Cardiovascular and Cerebrovascular Disease Risk Assessment Package and others. The Company is also engaged in the provision of vitro diagnostics (IVD) pipeline products, including consumer genetic testing products and disease screening products. The Company primarily conducts its businesses in domestic market.
Employees
196
Date Price Change Volume
26-10-07 HK$7.300 +0.41% 600
26-10-07 HK$7.270 +0.69% 202,400
26-10-06 HK$7.220 +2.70% 200,400
26-10-05 HK$7.030 -0.28% 120,200
26-10-02 HK$7.050 +0.50% 93,200
  1. Stock Market
  2. Stocks
  3. 6667 Stock